Misplaced Pages

30 May 2008

• curprev 15:4415:44, 30 May 2008 69.70.202.20 talk 35,858 bytes −1 →Major depressive disorder undo
• curprev 00:4900:49, 30 May 2008 Bhawthorne talk contribs 35,859 bytes −37 Began the process of moving links out of list and into the prose description. undo

24 May 2008

• curprev 19:4219:42, 24 May 2008 Paul gene talk contribs 35,896 bytes +624 one more critical reference undo

23 May 2008

• curprev 10:2410:24, 23 May 2008 Paul gene talk contribs 35,272 bytes −64 →Indications: rm tags - there are refs below, MDD is not the same as severe depression undo
• curprev 10:2310:23, 23 May 2008 Paul gene talk contribs 35,336 bytes −45 Rv zeta edits undo
• curprev 00:4800:48, 23 May 2008 Davidruben talk contribs m 35,381 bytes −1 shift image so as to remove white space that appears between "History" section header and the start of its text undo
• curprev 00:2400:24, 23 May 2008 Paul gene talk contribs m 35,382 bytes −2 →Major depressive disorder undo
• curprev 00:2300:23, 23 May 2008 Paul gene talk contribs 35,384 bytes +814 →Major depressive disorder: meta-analysis - duloxetine is not more effective than SSRIs undo

22 May 2008

• curprev 23:5123:51, 22 May 2008 Paul gene talk contribs 34,570 bytes +515 →Major depressive disorder: meta-analysis of pre-marketing trials undo
• curprev 23:4423:44, 22 May 2008 Paul gene talk contribs 34,055 bytes +558 →Major depressive disorder: effective in pre-marketing trials undo
• curprev 08:2408:24, 22 May 2008 VolkovBot talk contribs m 33,497 bytes +24 robot Adding: ru:Симбалта undo
• curprev 01:3001:30, 22 May 2008 Riemann Zeta talk contribs m 33,473 bytes +18 No edit summary undo

21 May 2008

• curprev 10:1510:15, 21 May 2008 Paul gene talk contribs 33,455 bytes 0 moved ref from PK to neuropathy undo
• curprev 10:1310:13, 21 May 2008 Paul gene talk contribs 33,455 bytes −2,133 Removed speculations and comparison of potency with venlafaxine. At clinical dosing they are of equal potency. undo
• curprev 09:5409:54, 21 May 2008 Jfdwolff talk contribs 35,588 bytes +22 →Pharmacology: citation still needed for MOA - how has this profile been established? undo
• curprev 06:3506:35, 21 May 2008 131.247.152.4 talk 35,566 bytes +188 Clarification regarding mechanism of action undo

18 May 2008

• curprev 19:3519:35, 18 May 2008 Paul gene talk contribs 35,378 bytes −35 moved in vitro reuptake data to Pharmacology undo
• curprev 12:3212:32, 18 May 2008 Paul gene talk contribs 35,413 bytes −598 →History: Del Japan - still no approval - not notable undo
• curprev 12:2912:29, 18 May 2008 Paul gene talk contribs 36,011 bytes −23 →History: copyedit undo
• curprev 12:2712:27, 18 May 2008 Paul gene talk contribs 36,034 bytes −169 Moved neuropathy research from history to indications undo
• curprev 12:2312:23, 18 May 2008 Paul gene talk contribs 36,203 bytes −273 →History: duloxetine for SUI history undo
• curprev 12:0112:01, 18 May 2008 Paul gene talk contribs 36,476 bytes −542 →History: Del promotion agreement - not notable undo
• curprev 11:5811:58, 18 May 2008 Paul gene talk contribs m 37,018 bytes +345 →History: ref undo
• curprev 11:5211:52, 18 May 2008 Paul gene talk contribs 36,673 bytes −299 →History: Rewrite of regulatory history undo
• curprev 04:1204:12, 18 May 2008 Jfdwolff talk contribs 36,972 bytes +24 →Adverse effects: needs to be turned into prose, or at the very least grouped by organ system undo
• curprev 02:0902:09, 18 May 2008 Paul gene talk contribs 36,948 bytes +290 →History: citation for 120-mg trial undo
• curprev 01:3701:37, 18 May 2008 Paul gene talk contribs 36,658 bytes +718 →History: Many wrongs: Bymaster discovered neither prozac nor duloxetine, LY227942 was a racemate, patent was granted in 1990 undo
• curprev 00:2300:23, 18 May 2008 Paul gene talk contribs 35,940 bytes −700 streamlined the lead undo

15 May 2008

• curprev 10:5010:50, 15 May 2008 Paul gene talk contribs 36,640 bytes −4 summation of risks and benefits in the lead, see Talk undo

14 May 2008

• curprev 15:3115:31, 14 May 2008 Jfdwolff talk contribs 36,644 bytes −230 rm speculation undo
• curprev 15:2815:28, 14 May 2008 Jfdwolff talk contribs m 36,874 bytes +5 breaking up long name undo
• curprev 15:2515:25, 14 May 2008 Jfdwolff talk contribs 36,869 bytes +1,776 →Stress urinary incontinence: expanding with the use of two systematic reviews undo
• curprev 15:0715:07, 14 May 2008 Jfdwolff talk contribs 35,093 bytes +2,409 updating journal references - no change to URLs as they need closer revision and replacement with peer-reviewed sources if possible undo
• curprev 14:3314:33, 14 May 2008 Jfdwolff talk contribs m 32,684 bytes −1 →History: oops undo
• curprev 14:2914:29, 14 May 2008 Jfdwolff talk contribs 32,685 bytes −1,866 trying to make the article WP:MEDMOS-compliant ("ongoing research" should be in "indications" unless it's not notable) undo
• curprev 14:0614:06, 14 May 2008 Jfdwolff talk contribs 34,551 bytes +59 moved opinion pieces out of intro, started updating references undo
• curprev 10:4910:49, 14 May 2008 Paul gene talk contribs 34,492 bytes +759 Included second opinion in the lead undo
• curprev 06:1606:16, 14 May 2008 Jfdwolff talk contribs 33,733 bytes −1,473 copyedit - restructured and removed some unsourced generalisations and frank errors, see talk undo

21 April 2008

• curprev 17:0217:02, 21 April 2008 Chowbok talk contribs m 35,206 bytes −7 clean up, Replaced: ® → (2) using AWB undo
• curprev 07:0807:08, 21 April 2008 202.86.117.210 talk 35,213 bytes −1 tidied wording to distinguish between efficacy and registered indications undo

15 April 2008

• curprev 00:3600:36, 15 April 2008 24.255.185.100 talk 35,214 bytes −233 →Fibromyalgia: Deleted potentially misleading & libelous sentence w/no citation. " Lastly, the primary researcher on the project has received more than $10,000 in consulting fees from Eli Lilly, undo

14 April 2008

• curprev 03:2803:28, 14 April 2008 99.224.36.122 talk 35,447 bytes −7 →Fibromyalgia: "11 percent" to "11%" undo
• curprev 03:2603:26, 14 April 2008 99.224.36.122 talk 35,454 bytes −6 →Side effects: "10 to 20 percent" changed to "10% to 20%" undo
• curprev 03:2403:24, 14 April 2008 99.224.36.122 talk 35,460 bytes −7 →History: "8.5 percent" to "8.5%" undo
• curprev 03:2003:20, 14 April 2008 99.224.36.122 talk 35,467 bytes −14 →Diabetic neuropathy: "percent" changed to "%" undo
• curprev 03:1803:18, 14 April 2008 99.224.36.122 talk 35,481 bytes −9 →Diabetic neuropathy: "31 percent" changed to "31%" undo
• curprev 03:1703:17, 14 April 2008 99.224.36.122 talk 35,490 bytes −7 →Generalized Anxiety Disorder: "3.1 percent" changed to "3.1%" undo

11 April 2008

• curprev 14:2214:22, 11 April 2008 Masoodamin talk contribs 35,497 bytes −6 →Side effects undo

6 April 2008

• curprev 21:1421:14, 6 April 2008 83.144.16.10 talk 35,503 bytes −2,101 →Financial undo

27 March 2008

• curprev 14:4514:45, 27 March 2008 Ravichandar84 talk contribs m 37,604 bytes +2,101 Reverted edits by 24.91.163.0 (talk) to last version by Aitias undo